MAPT and Alzheimer disease: AD is characterized by cognitive decline, memory loss, and behavioral changes, with its pathology marked by the accumulation of amyloid-beta (Aβ) plaques and neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau protein in the brain [2].